Research status of fetal hydrocephalus from 2003 to 2022 based on bibliometric analysis

Abstract

Hydrocephalus is the most common and devastating condition affecting the fetus. The aim of this study was to provide a comprehensive overview of the relevant literature through bibliometric analysis. The survey covers the articles related to congenital hydrocephalus published in the Web of Science Core Collection (WoSCC) database from January 1, 2003 to December 31, 2022. In addition to repeated literature, reviews and articles are included. We visualized the annual publication number, citation frequency, country/region, institution, author, periodical, and keywords with a range of software such as VOSviewer (1.6.18), Microsoft Excel 2019 (Redmond) and online analysis platform (https://bibliometric.com/ document). The results showed that the United States made the most important contribution to the research on fetal hydrocephalus. China's contribution has grown and developed strongly in recent years. The key words were mainly divided into four categories: basic research, epidemiology, treatment, and diagnostics. The number of publications related to fetal hydrocephalus has increased significantly, and it has a good development prospect in prenatal diagnosis and treatment.

Keywords

bibliometric analysis / congenital / human fetus / hydrocephalus

References

[1] Kalyvas AV, Kalamatianos T, Pantazi M, Lianos GD, Stranjalis G, Alexiou GA. Maternal environmental risk factors for congenital hydrocephalus: a systematic review. Neurosurg Focus. 2016; 41(5): E3.

[2] Bramall AN, Anton ES, Kahle KT, Fecci PE. Navigating the ventricles: novel insights into the pathogenesis of hydrocephalus. EBioMedicine. 2022; 78:103931.

[3] Tully HM, Dobyns WB. Infantile hydrocephalus: a review of epidemiology, classification and causes. Eur J Med Genet. 2014; 57(8): 359-368.

[4] Kundishora AJ, Singh AK, Allington G, et al. Genomics of human congenital hydrocephalus. Childs Nerv Syst. 2021; 37(11): 3325-3340.

[5] Partington MD. Congenital hydrocephalus. Neurosurg Clin N Am. 2001; 12(4): 737-742.

[6] Estey CM. Congenital hydrocephalus. Vet Clin North Am Small Anim Pract. 2016; 46(2): 217-229.

[7] Jin SC, Dong W, Kundishora AJ, et al. Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus. Nature Med. 2020; 26(11): 1754-1765.

[8] Hochstetler A, Raskin J, Blazer-Yost BL. Hydrocephalus: historical analysis and considerations for treatment. Eur J Med Res. 2022; 27(1): 168.

[9] Han Y, Wennersten SA, Lam MPY. Working the literature harder: what can text mining and bibliometric analysis reveal? Expert Rev Proteomics. 2019; 16(11-12): 871-873.

[10] van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84(2): 523-538.

[11] Choudhri AF, Siddiqui A, Khan NR, Cohen HL. Understanding bibliometric parameters and analysis. Radiographics. 2015; 35(3): 736-746.

[12] Kho ME, Brouwers MC. The systematic review and bibliometric network analysis (SeBriNA) is a new method to contextualize evidence. Part 1: description. J Clin Epidemiol. 2012; 65(9): 1010-1015.

[13] Berlinberg A, Bilal J, Riaz IB, Kurtzman DJB. The 100 top-cited publications in psoriatic arthritis: a bibliometric analysis. Int J Dermatol. 2019; 58(9): 1023-1034.

[14] Xiao Y, Deng Z, Tan H, Jiang T, Chen Z. Bibliometric analysis of the knowledge base and future trends on sarcopenia from 1999-2021. Int J Environ Res Public Health. 2022; 19(14):8866.

[15] Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011; 364(11): 993-1004.

[16] Wang C, Jing H, Sun Z, et al. A bibliometric analysis of primary aldosteronism research from 2000 to 2020. Front Endocrinol. 2021; 12:665912.

[17] Zhang MM, Yang KL, Cui YC, et al. Current trends and research topics regarding intestinal organoids: an overview based on bibliometrics. Front Cell Dev Biol. 2021; 9:609452.

[18] Wu H, Tong L, Wang Y, Yan H, Sun Z. Bibliometric analysis of global research trends on ultrasound microbubble: a quickly developing field. Front Pharmacol. 2021; 12:646626.

[19] Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sánchez E, Gutiérrez-Rojas L, Meana JJ. Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs. 2018; 32(5): 411-420.

[20] Malagón-Valdez J. Congenital hydrocephalus. Rev Neurol. 2006; 42(suppl 3): 39-44.

[21] von Koch CS, Gupta N, Sutton LN, Sun PP. In utero surgery for hydrocephalus. Childs Nerv Syst. 2003; 19(7-8): 574-586.

[22] Nomura ML, Barini R, De Andrade KC, et al. Congenital hydrocephalus: gestational and neonatal outcomes. Arch Gynecol Obstet. 2010; 282(6): 607-611.

[23] Chiu TH, Haliza G, Lin YH, et al. A retrospective study on the course and outcome of fetal ventriculomegaly. Taiwan J Obstet Gynecol. 2014; 53(2): 170-177.

[24] Gupta JK, Bryce FC, Lilford RJ. Management of apparently isolated fetal ventriculomegaly. Obstet Gynecol Surv. 1994; 49(10): 716-721.

[25] Hannon T, Tennant PWG, Rankin J, Robson SC. Epidemiology, natural history, progression, and postnatal outcome of severe fetal ventriculomegaly. Obstet Gynecol. 2012; 120(6): 1345-1353.

[26] Garel C. Fetal cerebral biometry: normal parenchymal findings and ventricular size. Eur Radiol. 2005; 15(4): 809-813.

[27] Ware AL, Kulesz PA, Orkisz JS, Arrington CN, Bowman RM, Fletcher JM. Long-term intellectual and fine motor outcomes in spina bifida are related to myelomeningocele repair and shunt intervention history. J Int Neuropsychol Soc. 2020; 26(4): 364-371.

[28] Fieggen G, Fieggen K, Stewart C, et al. Spina bifida: a multidisciplinary perspective on a many-faceted condition. S Afr Med J. 2014; 104(3): 213-217.

[29] McCarthy DJ, Sheinberg DL, Luther E, McCrea HJ. Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review. Neurosurg Focus. 2019; 47(4): E5.

[30] Jimenez-Gomez A, Castillo H, Burckart C, Castillo J. Endoscopic third ventriculostomy to address hydrocephalus in Africa: a call for education and community-based rehabilitation. J Pediatr Rehabil Med. 2017; 10(3-4): 267-273.

[31] Verhagen JMA, Schrander-Stumpel CTRM, Krapels IPC, et al. Congenital hydrocephalus in clinical practice: a genetic diagnostic approach. Eur J Med Genet. 2011; 54(6): e542-e547.

[32] Lifshutz JI, Johnson WD. History of hydrocephalus and its treatments. Neurosurg Focus. 2001; 11(2): 1-5.

[33] Glick PL, Harrison MR, Nakayama DK, et al. Management of ventriculomegaly in the fetus. J Pediatr. 1984; 105(1): 97-105.

[34] Chi JH, Fullerton HJ, Gupta N. Time trends and demographics of deaths from congenital hydrocephalus in children in the United States: National Center for Health Statistics data, 1979 to 1998. J Neurosurg. 2005; 103(suppl 2): 113-118.

[35] Frigoletto Jr., FD, Birnholz JC, Greene MF. Antenatal treatment of hydrocephalus by ventriculoamniotic shunting. J Am Med Assoc. 1982; 248(19): 2496-2497.

[36] Michejda M, Queenan JT, McCullough D. Present status of intrauterine treatment of hydrocephalus and its future. Am J Obstet Gynecol. 1986; 155(4): 873-882.

[37] Bruner JP, Davis G, Tulipan N. Intrauterine shunt for obstructive hydrocephalus—still not ready. Fetal Diagn Ther. 2006; 21(6): 532-539.

[38] Verma R, Srivastava C, Ojha B, et al. Complications encountered with ETV in infants with congenital hydrocephalus. Neurol India. 2021; 69(suppl): 520.

[39] Oria M, Duru S, Scorletti F, et al. Intracisternal BioGlue injection in the fetal lamb: a novel model for creation of obstructive congenital hydrocephalus without additional chemically induced neuroinflammation. J Neurosurg Pediatr. 2019; 24: 652-662.

[40] Wang KC, Lee JY, Kim SK, Phi JH, Cho BK. Fetal ventriculomegaly: postnatal management. Childs Nerv Syst. 2011; 27(10): 1571-1573.

[41] Miller JM, McAllister JP. Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res. 2007; 4:5.

[42] Baldauf J, Oertel J, Gaab MR, Schroeder HWS. Endoscopic third ventriculostomy in children younger than 2 years of age. Childs Nerv Syst. 2007; 23(6): 623-626.

[43] Balthasar AJR, Kort H, Cornips EMJ, Beuls EAM, Weber JW, Vles JSH. Analysis of the success and failure of endoscopic third ventriculostomy in infants less than 1 year of age. Childs Nerv Syst. 2007; 23(2): 151-155.

[44] Constantini S, Sgouros S, Kulkarni A. Neuroendoscopy in the youngest age group. World neurosurgery. 2013; 79(suppl 2): S23.e1-S23.e11.

[45] Fritsch MJ, Kienke S, Ankermann T, Padoin M, Mehdorn HM. Endoscopic third ventriculostomy in infants. J Neurosurg. 2005; 103(suppl 1): 50-53.

[46] Gorayeb RP, Cavalheiro S, Zymberg ST. Endoscopic third ventriculostomy in children younger than 1 year of age. J Neurosurg. 2004; 100(suppl 5): 427-429.

[47] O'Brien DF, Seghedoni A, Collins DR, Hayhurst C, Mallucci CL. Is there an indication for ETV in young infants in aetiologies other than isolated aqueduct stenosis? Childs Nerv Syst. 2006; 22(12): 1565-1572.

[48] Wagner W, Koch D. Mechanisms of failure after endoscopic third ventriculostomy in young infants. J Neurosurg. 2005; 103(suppl 1): 43-49.

[49] El Damaty A, Marx S, Cohrs G, et al. ETV in infancy and childhood below 2 years of age for treatment of hydrocephalus. Childs Nerv Syst. 2020; 36(11): 2725-2731.

RIGHTS & PERMISSIONS

2024 The Author(s). Ibrain published by Affiliated Hospital of Zunyi Medical University and Wiley-VCH GmbH.